Compound 110
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(F)(F)F)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCC(CC1)=Cc1ccccc1
- InChi:
InChI=1S/C39H45F3N6O4S3/c1-47(2)21-19-30(26-53-32-11-7-4-8-12-32)45-35-18-17-33(24-37(35)54(49,50)39(40,41)42)55(51,52)46-38-34-20-22-48(25-36(34)43-27-44-38)31-15-13-29(14-16-31)23-28-9-5-3-6-10-28/h3-12,17-18,23-24,27,30-31,45H,13-16,19-22,25-26H2,1-2H3,(H,43,44,46)/t30-,31?/m1/s1
- InChiKey:
KDXMNAXJDGEAMV-PBBFAOSKSA-N
External links
68051292 |
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 63 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.93 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 814.26 g/mol | |||
HBA | 10 | |||
HBD | 2 | |||
HBA + HBD | 12 | |||
AlogP | 6.31 | |||
TPSA | 124.60 | |||
RB | 14 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 63 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 5.93 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5244 | Navitoclax | DB12340 | |
0.3967 | Sulfaisodimidine | DB13283 | |
0.3813 | GDC-0349 | DB13072 | |
0.3767 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3656 | Cyclothiazide | DB00606 | |
0.3591 | Sulfametomidine | DB13485 | |
0.3511 | (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE | DB08039 | |
0.3505 | Venetoclax | DB11581 | |
0.3500 | Presatovir | DB12165 | |
0.3469 | (4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol | DB08448 | |
0.3425 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3420 | Quinupristin | DB01369 | |
0.3357 | 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine | DB07585 | |
0.3333 | Cenicriviroc | DB11758 | |
0.3333 | Sparsentan | DB12548 |